This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
LyondellBasell (LYB) Offers Polybatch Effects FROST Masterbatches
by Zacks Equity Research
The new product grades demonstrate how LyondellBasell (LYB) is developing solutions for everyday sustainable living.
DOW & SCGC Ink MOU to Transform 200KTA of Plastic Waste
by Zacks Equity Research
The deal will allow both companies to play a vital role in promoting greater circularity in the region by leveraging DOW's complementary portfolio and research and development capabilities.
DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?
by Zacks Equity Research
DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
by Zacks Equity Research
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Should You Invest in the Vanguard Materials ETF (VAW)?
by Zacks Equity Research
Sector ETF report for VAW
Eastman (EMN) Partners Debrand to Recycle Textile Waste
by Zacks Equity Research
Eastman (EMN) & Debrand demonstrate the transformational power of molecular recycling technology to address the textile waste challenge.
DOW Increases Propylene Glycol Capacity in Thailand Facility
by Zacks Equity Research
DOW's propylene glycol business upgrades fundamental chemical building blocks to make high-quality ingredients for cosmetics, food, pharmaceuticals and a wide range of everyday items.
Philips' (PHG) Reports Positive AI-Powered Cardiac Study Data
by Zacks Equity Research
Philips' (PHG) AI-powered cardiac monitoring solutions demonstrate significantly lower re-admissions and a higher rate of survival in the retrospective study evaluating it in stroke patients.
Masimo's (MASI) New Offering to Serve Personalized Audio Market
by Zacks Equity Research
Masimo's (MASI) new product offering is expected to enable it to expand its footprint in the personalized hearables market by offering personalized listening experiences.
Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?
by Zacks Equity Research
Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.
DOW & Freepoint Ink Agreement to Transform Plastic Waste
by Zacks Equity Research
DOW will use the circular liquid supply to create new products using virgin-grade equivalent polymers, replacing those generated from conventional feedstock.
Veeva's (VEEV) Vault Basics to Boost Efficiency for Biotechs
by Zacks Equity Research
Veeva (VEEV) announces the availability of Vault Basics for biotechs, which aims to deliver complete and pre-validated solutions for expanding businesses.
AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft
by Zacks Equity Research
AxoGen (AXGN) starts the process of BLA submission to the FDA for the approval of its Avance Nerve Graft.
Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food
by Zacks Equity Research
Arcadia Biosciences (RKDA) sells its GoodWheat brand to scale up its wheat IP.
BD's (BDX) FDA-Approved Test to Offer Wider Testing Access
by Zacks Equity Research
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
LyondellBasell (LYB) Adds New Distribution Hub in Hungary
by Zacks Equity Research
This distribution facility in Hungary is a significant addition to LyondellBasell's (LYB) global footprint.
Three Reasons to Retain AMN Healthcare (AMN) Stock for Now
by Zacks Equity Research
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.
HealthEquity (HQY) Closes Conduent's BenefitWallet Acquisition
by Zacks Equity Research
HealthEquity (HQY) completes the acquisition of Conduent's BenefitWallet HSA portfolio. This is likely to further strengthen the HSA business of HealthEquity.
FMC & Optibrium Partner for Crop Protection Technologies
by Zacks Equity Research
FMC will use Optibrium's Cerella and StarDrop technologies to expand its internal research and development.
Here's Why You Should Hold Onto Dow (DOW) Stock for Now
by Zacks Equity Research
While Dow (DOW) faces headwinds from soft demand in certain markets, it gains on cost and productivity initiatives and growth projects.
Eastman (EMN) & Lubrizol to Enhance TPE Overmolding Adhesion
by Zacks Equity Research
Eastman (EMN) & Lubrizol's collaboration stems from a shared understanding of the value of overmolding in manufacturing while improving product performance and aesthetics in consumer goods.
Merit Medical (MMSI) to Expand Product Suite Via New Launch
by Zacks Equity Research
Merit Medical's (MMSI) latest additions to its embolotherapy portfolio are likely to improve the patient experience.
Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio
by Zacks Equity Research
Veeva System's (VEEV) strong product demand and strategic deals raise optimism about the stock.
GE HealthCare (GEHC), Medis Medical Partner to Aid CAD Therapy
by Zacks Equity Research
GE HealthCare (GEHC) and Medis Medical collaborate to boost precision care for coronary artery disease treatment.
ArcelorMittal (MT) Advances Green Steel With Gijon EAF Project
by Zacks Equity Research
ArcelorMittal's (MT) electric arc furnace at Gijon aims to reduce CO2 emissions by more than 35% and support growing low-carbon steel demand.